To encourage antibiotic innovation, the U.S. is considering major policy changes like the PASTEUR Act. This bipartisan bill ...

In an effort to beat drug resistance, researchers are focusing on early diagnosis, biomarker research, rational antibiotic ...

Imagine going to the hospital for a bacterial ear infection and hearing your doctor say, "We're out of options." It may sound ...

Kamini Walia, senior scientist at ICMR (Indian Council of Medical Research), explains how the overuse of antibiotics is ...

While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...

An international research team has demonstrated that Janus nanoparticles can disrupt the defenses of drug-resistant ...

From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...

But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter phase ...

Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs — so they don’t work well, or even at all — means new ones are urgently needed.

By Lisa Held for Civil Eats. Broadcast version by Brett Peveto for Nebraska News Connection reporting for the Solutions ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. The drug, called gepotidacin, ...

An international research team led by The University of Osaka has demonstrated that two-faced Janus nanoparticles can restore ...